The potential regenerative nature of our therapeutic approach is what sparked our founders’ idea to name the company Aspen – the first tree to regenerate after destruction, because of its extensive interconnected root systems which also mirror the neural networks of the brain.

about us »

Personalized Regenerative Cell
Therapies for Parkinson’s Disease

Built from Your Own Cells

Our investigational single-dose therapy begins with a patient’s own cells, creating a personalized therapy that is made individually for each patient.

For Parkinson’s disease, this approach is designed to replace the lost dopamine-producing cells and the underlying neural circuitry lost over time. Our goal is to help restore motor and non-motor function, rebuild important brain connections, and improve quality of life.

learn more »

Built to Scale with Precision

The Future is Now: Aspen is Leading at the Intersection of High-tech and Biotech

Combining automation, artificial intelligence, machine learning, and genomics-based bioinformatics, we are working to develop an intelligent manufacturing platform that enables the production of high-quality personalized cell therapies at commercial scale.

learn more »

From Lab to Clinic, We Aim to Transform Patient Lives

Driven by pioneering science and guided by a world-class team, Aspen is advancing personalized investigational cell therapies for Parkinson’s disease. Our research, manufacturing innovation, and growing clinical experience are helping turn scientific possibility into meaningful progress for patients.